<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01749982</url>
  </required_header>
  <id_info>
    <org_study_id>AAAJ1959</org_study_id>
    <nct_id>NCT01749982</nct_id>
  </id_info>
  <brief_title>A Preliminary Study of Choline and Betaine Supplementation Among Adults Exposed to Arsenic in Bangladesh</brief_title>
  <acronym>CABS</acronym>
  <official_title>A Pilot Study of Choline and Betaine Supplementation in Arsenic-exposed Individuals in Bangladesh</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Roughly 140 million people worldwide are chronically exposed to As-contaminated drinking
      water at concentrations exceeding the World Health Organization (WHO) standard of 10 Âµg/L.
      Arsenic is a class I carcinogen known to cause several types of cancer and ischemic heart
      disease. Metabolism of inorganic As (InAs), which facilitates urinary As excretion, relies on
      one-carbon metabolism and involves two methylation steps; both utilize S-adenosylmethionine
      (SAM) as the methyl donor. SAM biosynthesis relies on B vitamins including folate and B12 for
      the recruitment and transfer of methyl groups, but other nutrients, including choline and
      betaine, also contribute to the methyl pool. Our recent findings from a cross-sectional study
      of Bangladeshi adults exposed to a wide range of As concentrations in drinking water show
      that plasma choline and betaine concentrations are positively associated with As methylation.
      These findings suggest that choline and/or betaine may play an important role in As
      methylation and elimination and that simple interventions may have therapeutic potential for
      the many populations at risk for As-induced health effects.

      The investigators aim to recruit and follow 60 participants for this pilot study which will
      allow us to 1) assess the acceptance of choline and betaine supplements, 2) monitor
      participants for any potential side effects, 3) identify any difficulties that might be
      encountered in daily follow-up, and 4) generate preliminary data regarding the effects of
      choline and/or betaine supplementation on arsenic methylation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Urinary % Monomethyl Arsenic</measure>
    <time_frame>From baseline to 8 weeks after the start of the intervention (week 8 - baseline)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Urinary % Inorganic Arsenic</measure>
    <time_frame>From baseline to 8 weeks after the start of the intervention (week 8 - baseline)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Urinary % Dimethyl Arsenic</measure>
    <time_frame>From baseline to 8 weeks after the start of the intervention (week 8 - baseline)</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Arsenic Metabolites Measured in Urine</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo tablets</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Choline bitartrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Choline bitartrate 700 mg by mouth daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Betaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Betaine 1000 mg by mouth daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Choline bitartrate + Betaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Choline bitartrate 700 mg + Betaine 1000 mg daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Choline bitartrate</intervention_name>
    <arm_group_label>Choline bitartrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Betaine</intervention_name>
    <arm_group_label>Betaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Choline bitartrate + Betaine</intervention_name>
    <arm_group_label>Choline bitartrate + Betaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 20-65

          -  Absence of all exclusion criteria

        Exclusion Criteria:

          -  women who are currently pregnant at the time of recruitment and/or plan to become
             pregnant within 2 months

          -  individuals taking nutritional supplements at the time of recruitment

          -  individuals who have taken nutritional supplements within the last 3 months

          -  participants enrolled in any other clinical trial

          -  women who are currently breastfeeding

          -  individuals known to have coronary heart disease, cerebrovascular disease,
             hypertension, renal disease, chronic obstructive pulmonary disease, asthma, cancer, or
             liver disease

          -  participants with protein or glucose in their urine sample (dipstick test)

          -  individuals whose drinking water history is complete for &lt; 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Megan N Hall, ScD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Columbia University Arsenic Research Project</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2012</study_first_submitted>
  <study_first_submitted_qc>December 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2012</study_first_posted>
  <results_first_submitted>August 14, 2014</results_first_submitted>
  <results_first_submitted_qc>August 14, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 28, 2014</results_first_posted>
  <last_update_submitted>August 14, 2014</last_update_submitted>
  <last_update_submitted_qc>August 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Megan Hall</investigator_full_name>
    <investigator_title>Assistant Professor of Epidemiology</investigator_title>
  </responsible_party>
  <keyword>arsenic</keyword>
  <keyword>Bangladesh</keyword>
  <keyword>choline</keyword>
  <keyword>betaine</keyword>
  <keyword>methylation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Choline</mesh_term>
    <mesh_term>Betaine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Placebo tablets
Placebo</description>
        </group>
        <group group_id="P2">
          <title>Choline Bitartrate</title>
          <description>Choline bitartrate 700 mg by mouth daily
Choline bitartrate</description>
        </group>
        <group group_id="P3">
          <title>Betaine</title>
          <description>Betaine 1000 mg by mouth daily
Betaine</description>
        </group>
        <group group_id="P4">
          <title>Choline Bitartrate + Betaine</title>
          <description>Choline bitartrate 700 mg + Betaine 1000 mg daily
Choline bitartrate + Betaine</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Placebo tablets
Placebo</description>
        </group>
        <group group_id="B2">
          <title>Choline Bitartrate</title>
          <description>Choline bitartrate 700 mg by mouth daily
Choline bitartrate</description>
        </group>
        <group group_id="B3">
          <title>Betaine</title>
          <description>Betaine 1000 mg by mouth daily
Betaine</description>
        </group>
        <group group_id="B4">
          <title>Choline Bitartrate + Betaine</title>
          <description>Choline bitartrate 700 mg + Betaine 1000 mg daily
Choline bitartrate + Betaine</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="15"/>
            <count group_id="B5" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.0" lower_limit="21.0" upper_limit="42.0"/>
                    <measurement group_id="B2" value="34.0" lower_limit="25.0" upper_limit="43.0"/>
                    <measurement group_id="B3" value="29.0" lower_limit="25.0" upper_limit="45.0"/>
                    <measurement group_id="B4" value="32.0" lower_limit="20.0" upper_limit="48.0"/>
                    <measurement group_id="B5" value="31.0" lower_limit="21" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Bangladesh</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Urinary % Monomethyl Arsenic</title>
        <time_frame>From baseline to 8 weeks after the start of the intervention (week 8 - baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo tablets
Placebo</description>
          </group>
          <group group_id="O2">
            <title>Choline Bitartrate</title>
            <description>Choline bitartrate 700 mg by mouth daily
Choline bitartrate</description>
          </group>
          <group group_id="O3">
            <title>Betaine</title>
            <description>Betaine 1000 mg by mouth daily
Betaine</description>
          </group>
          <group group_id="O4">
            <title>Choline Bitartrate + Betaine</title>
            <description>Choline bitartrate 700 mg + Betaine 1000 mg daily
Choline bitartrate + Betaine</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Urinary % Monomethyl Arsenic</title>
          <units>percentage of total urinary arsenic</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="-8.4" upper_limit="7.8"/>
                    <measurement group_id="O2" value="0.24" lower_limit="-4.3" upper_limit="9.4"/>
                    <measurement group_id="O3" value="-0.06" lower_limit="-11.6" upper_limit="5.4"/>
                    <measurement group_id="O4" value="-3.2" lower_limit="-8.9" upper_limit="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Urinary % Inorganic Arsenic</title>
        <time_frame>From baseline to 8 weeks after the start of the intervention (week 8 - baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo tablets
Placebo</description>
          </group>
          <group group_id="O2">
            <title>Choline Bitartrate</title>
            <description>Choline bitartrate 700 mg by mouth daily
Choline bitartrate</description>
          </group>
          <group group_id="O3">
            <title>Betaine</title>
            <description>Betaine 1000 mg by mouth daily
Betaine</description>
          </group>
          <group group_id="O4">
            <title>Choline Bitartrate + Betaine</title>
            <description>Choline bitartrate 700 mg + Betaine 1000 mg daily
Choline bitartrate + Betaine</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Urinary % Inorganic Arsenic</title>
          <units>percentage of total urinary arsenic</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" lower_limit="-13.2" upper_limit="10.3"/>
                    <measurement group_id="O2" value="-0.87" lower_limit="-21.7" upper_limit="20.8"/>
                    <measurement group_id="O3" value="-1.25" lower_limit="-8.2" upper_limit="8.2"/>
                    <measurement group_id="O4" value="-1.7" lower_limit="-12.7" upper_limit="26.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Urinary % Dimethyl Arsenic</title>
        <time_frame>From baseline to 8 weeks after the start of the intervention (week 8 - baseline)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo tablets
Placebo</description>
          </group>
          <group group_id="O2">
            <title>Choline Bitartrate</title>
            <description>Choline bitartrate 700 mg by mouth daily
Choline bitartrate</description>
          </group>
          <group group_id="O3">
            <title>Betaine</title>
            <description>Betaine 1000 mg by mouth daily
Betaine</description>
          </group>
          <group group_id="O4">
            <title>Choline Bitartrate + Betaine</title>
            <description>Choline bitartrate 700 mg + Betaine 1000 mg daily
Choline bitartrate + Betaine</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Urinary % Dimethyl Arsenic</title>
          <units>percentage of total urinary arsenic</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.8" lower_limit="-11.5" upper_limit="21.6"/>
                    <measurement group_id="O2" value="0.65" lower_limit="-16.4" upper_limit="15.3"/>
                    <measurement group_id="O3" value="-0.87" lower_limit="-13.4" upper_limit="13.9"/>
                    <measurement group_id="O4" value="5.45" lower_limit="-20.8" upper_limit="18.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Placebo tablets
Placebo</description>
        </group>
        <group group_id="E2">
          <title>Choline Bitartrate</title>
          <description>Choline bitartrate 700 mg by mouth daily
Choline bitartrate</description>
        </group>
        <group group_id="E3">
          <title>Betaine</title>
          <description>Betaine 1000 mg by mouth daily
Betaine</description>
        </group>
        <group group_id="E4">
          <title>Choline Bitartrate + Betaine</title>
          <description>Choline bitartrate 700 mg + Betaine 1000 mg daily
Choline bitartrate + Betaine</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This is a pilot study that is not powered to detect statistically significant effects. The results given here are descriptive.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Megan N Hall</name_or_title>
      <organization>Columbia University</organization>
      <phone>212-305-3161</phone>
      <email>mh2825@columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

